Caturkarda Depo Bangunan Annual cash flow by MarketWatch. View DEPO net cash flow, operating cash flow, operating expenses and cash dividends.

Depomed's full-year guidancce has been slightly altered, moving from in the range of $485 million to $525 million, to the range of $490 million to $520 million. DEPO stock is up 14.7% Monday.

Depo-Provera, an injectable contraceptive, will come with a special warning that links prolonged use of the drug with bone density loss, the government said Wednesday. The Food and Drug ...